Amphetamine increases motivation of humans and mice as measured by breakpoint, but does not affect an Electroencephalographic biomarker-Reference-Cited by-同舟云学术

Amphetamine increases motivation of humans and mice as measured by breakpoint, but does not affect an Electroencephalographic biomarker

Published:2024-01-02 Issue: Volume: Page:
ISSN:1530-7026
Container-title:Cognitive, Affective, & Behavioral Neuroscience
language:en
Short-container-title:Cogn Affect Behav Neurosci

Author:

Noback Michael,Bhakta Savita G.,Talledo Jo A.,Kotz Juliana E.,Benster Lindsay,Roberts Benjamin Z.,Nungaray John A.,Light Gregory A.,Swerdlow Neal R.,Brigman Jonathan L.,Cavanagh James F.,Young Jared W.

Publisher

Springer Science and Business Media LLC

Subject

Behavioral Neuroscience,Cognitive Neuroscience

Link

https://link.springer.com/content/pdf/10.3758/s13415-023-01150-z.pdf

Reference55 articles.

1. Amitai, N., Powell, S. B., & Young, J. W. (2019). Phencyclidine increased while isolation rearing did not affect progressive ratio responding in rats: Investigating potential models of amotivation in schizophrenia. Behavior Brain Research, 364, 413–422. https://doi.org/10.1016/j.bbr.2017.11.026

2. Barch, D. M., Carter, C. S., Arnsten, A., Buchanan, R. W., Cohen, J. D., Geyer, M., ..., Heinssen, R. (2009). Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: Proceedings of the third CNTRICS meeting. Schizophrenia Bulletin, 35(1), 109-114. https://doi.org/10.1093/schbul/sbn163

3. Barkus, C., Feyder, M., Graybeal, C., Wright, T., Wiedholz, L., Izquierdo, A., ..., Holmes, A. (2012). Do GluA1 knockout mice exhibit behavioral abnormalities relevant to the negative or cognitive symptoms of schizophrenia and schizoaffective disorder? Neuropharmacology, 62(3), 1263-1272. https://doi.org/10.1016/j.neuropharm.2011.06.005

4. Barrett, S. P., Pihl, R. O., Benkelfat, C., Brunelle, C., Young, S. N., & Leyton, M. (2008). The role of dopamine in alcohol self-administration in humans: individual differences. Eur Neuropsychopharmacology, 18(6), 439–447. https://doi.org/10.1016/j.euroneuro.2008.01.008

5. Bensadoun, J. C., Brooks, S. P., & Dunnett, S. B. (2004). Free operant and discrete trial performance of mice in the nine-hole box apparatus: validation using amphetamine and scopolamine. Psychopharmacology (Berlin), 174(3), 396–405. https://doi.org/10.1007/s00213-003-1751-0